Mismatch repair deficiency associated with complete remission to combination programmed cell death ligand immune therapy in a patient with sporadic urothelial carcinoma: immunotheranostic considerations
==========================================================================================================================================================================================================

* Michael P. Castro
* Neal Goldstein